Get the Stockscreener App
1.44
0.35%
0.005
Salarius Pharmaceuticals Inc Stock (SLRX) Forecast
The Salarius Pharmaceuticals Inc (SLRX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $110.84, representing a +7,598% increase from the current price of $1.44. The highest analyst price target is $107.29, and the lowest is $114.40.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month SLRX Price Target
Average 154.63
(+10,638% Upside)
Is Salarius Pharmaceuticals Inc (SLRX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 39.24 | Neutral |
| STOCH(9,6) | 13.02 | Buy |
| STOCHRSI(14) | 9.1375 | Buy |
| MACD(12,26) | -0.1116 | Buy |
| ADX(14) | 21.84 | Neutral |
| William %R | -88.46 | Buy |
| CCI(14) | -114.55 | Sell |
Buy: 4
Sell: 1
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.5865
Sell
|
1.5282
Sell
|
| MA20 |
1.5613
Sell
|
1.6031
Sell
|
| MA50 |
1.9381
Sell
|
1.9029
Sell
|
| MA100 |
2.517
Sell
|
2.4709
Sell
|
| MA200 |
3.5433
Sell
|
3.647
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, SLRX could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 11 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on SLRX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 39.24 indicates that SLRX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 13.02 indicates that SLRX is oversold. This indicates that SLRX price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 9.1375 indicates that SLRX is oversold. This suggests that SLRX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 21.84 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -114.55 indicates that SLRX is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term SLRX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Salarius Pharmaceuticals Inc financial reports and earnings history, Salarius Pharmaceuticals Inc (SLRX) stock could reach $237.96 by 2030, $168.95 by 2040 and $560.69 by 2050. See the projected annual prices until 2050 of the Salarius Pharmaceuticals Inc stock below:
- Salarius Pharmaceuticals Inc (SLRX) is expected to reach an average price of $49.02 in 2035, with a high prediction of $55.78 and a low estimate of $49.05. This indicates an $3,304% rise from the last recorded price of $1.44.
- Salarius Pharmaceuticals Inc (SLRX) stock is projected to chart a bullish course in 2040, with an average price target of $161.27, representing an $11,099% surge from its current level. The forecast ranges from a conservative $161.51 to a sky-high $168.95.
- Our analysts predict Salarius Pharmaceuticals Inc (SLRX) to jump 22,564% by 2045, soaring from $327.40 to an average price of $326.36, potentially reaching $335.18. While $327.40 is the low estimate, the potential upside is significant.
- Salarius Pharmaceuticals Inc (SLRX) stock is expected to climb by 2050, reaching an average of $548.47, a $37,988% jump from its current level. However, a wide range of estimates exists, with high and low targets of $560.69 and $549.56, respectively, highlighting the market's uncertainty.
Salarius Pharmaceuticals Inc Stock (SLRX) Year by Year Forecast
Salarius Pharmaceuticals Inc Stock (SLRX) Price Forecast for 2024
Our forecast for SLRX stock price in 2024 now indicates an average price target of $181.89 with a high forecast of $363.35 and a low forecast of $0.43. The average prediction reflects an increase of +12,531% from the last recorded price of $1.44.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2024 | $124.54 | $114.40 | $107.29 | +8,549% |
| December, 2024 | $127.07 | $129.71 | $132.97 | +8,724% |
Salarius Pharmaceuticals Inc Stock (SLRX) Price Forecast for 2025
Salarius Pharmaceuticals Inc Stock (SLRX) is expected to reach an average price of $161.73 in 2025, with a high prediction of $194.87 and a low estimate of $128.60. This indicates an +11,131% rise from the last recorded price of $1.44.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $126.86 | $128.60 | $122.22 | +8,709% |
| February, 2025 | $156.76 | $131.86 | $145.02 | +10,786% |
| March, 2025 | $194.16 | $171.14 | $194.77 | +13,384% |
| April, 2025 | $194.25 | $192.92 | $194.87 | +13,389% |
| May, 2025 | $193.23 | $193.46 | $192.83 | +13,319% |
| June, 2025 | $183.00 | $185.00 | $185.00 | +12,609% |
| July, 2025 | $162.66 | $164.66 | $172.22 | +11,196% |
| August, 2025 | $159.69 | $161.94 | $163.68 | +10,990% |
| September, 2025 | $164.72 | $162.70 | $159.97 | +11,339% |
| October, 2025 | $168.64 | $166.47 | $165.24 | +11,611% |
| November, 2025 | $164.31 | $165.66 | $164.51 | +11,311% |
| December, 2025 | $164.89 | $162.28 | $162.37 | +11,351% |
Salarius Pharmaceuticals Inc Stock (SLRX) Price Forecast for 2026
The predicted value for Salarius Pharmaceuticals Inc (SLRX) in 2026 is set at an average of $135.51. Estimates vary from a peak of $162.20 to a trough of $108.81, indicating an +9,310% surge from the present price of $1.44.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $160.50 | $161.60 | $162.20 | +11,046% |
| February, 2026 | $153.13 | $152.84 | $159.25 | +10,534% |
| March, 2026 | $140.40 | $143.15 | $148.64 | +9,650% |
| April, 2026 | $106.56 | $108.81 | $136.42 | +7,300% |
| May, 2026 | $124.59 | $126.59 | $122.21 | +8,552% |
| June, 2026 | $124.87 | $123.74 | $122.11 | +8,572% |
| July, 2026 | $121.78 | $127.02 | $126.13 | +8,357% |
| August, 2026 | $122.31 | $123.16 | $120.31 | +8,394% |
| September, 2026 | $122.73 | $122.09 | $120.82 | +8,423% |
| October, 2026 | $122.36 | $124.00 | $122.37 | +8,397% |
| November, 2026 | $114.28 | $115.72 | $119.38 | +7,836% |
| December, 2026 | $110.69 | $110.94 | $110.04 | +7,587% |
Salarius Pharmaceuticals Inc Stock (SLRX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Salarius Pharmaceuticals Inc (SLRX) is $97.85, with a high forecast of $109.90 and a low forecast of $85.80. This indicates an +6,695% increase from the last price of $1.44.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $111.46 | $110.77 | $109.32 | +7,641% |
| February, 2027 | $111.14 | $111.09 | $109.90 | +7,618% |
| March, 2027 | $110.53 | $111.61 | $109.70 | +7,576% |
| April, 2027 | $109.43 | $109.76 | $109.62 | +7,499% |
| May, 2027 | $105.78 | $106.91 | $107.59 | +7,246% |
| June, 2027 | $103.80 | $104.33 | $104.09 | +7,108% |
| July, 2027 | $99.94 | $100.10 | $100.88 | +6,841% |
| August, 2027 | $99.67 | $98.71 | $98.78 | +6,822% |
| September, 2027 | $97.49 | $98.09 | $99.19 | +6,670% |
| October, 2027 | $93.61 | $93.99 | $96.48 | +6,401% |
| November, 2027 | $89.66 | $90.02 | $92.15 | +6,126% |
| December, 2027 | $84.85 | $85.80 | $88.77 | +5,793% |
Salarius Pharmaceuticals Inc Stock (SLRX) Price Forecast for 2028
In 2028, Salarius Pharmaceuticals Inc (SLRX) is projected to reach an average price of $64.10, with a high projection of $83.83 and a low estimate of $44.36. This indicates an +4,351% rise from the last price of $1.44.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $81.84 | $82.46 | $83.83 | +5,583% |
| February, 2028 | $78.98 | $79.36 | $81.14 | +5,385% |
| March, 2028 | $77.49 | $77.53 | $77.66 | +5,281% |
| April, 2028 | $73.97 | $74.10 | $76.48 | +5,037% |
| May, 2028 | $70.51 | $70.63 | $73.03 | +4,796% |
| June, 2028 | $65.26 | $66.18 | $69.13 | +4,432% |
| July, 2028 | $62.73 | $62.87 | $64.30 | +4,257% |
| August, 2028 | $58.38 | $58.47 | $61.56 | +3,954% |
| September, 2028 | $55.50 | $55.61 | $57.39 | +3,754% |
| October, 2028 | $51.65 | $51.81 | $54.33 | +3,487% |
| November, 2028 | $47.53 | $47.70 | $50.30 | +3,201% |
| December, 2028 | $44.18 | $44.36 | $46.40 | +2,968% |
Salarius Pharmaceuticals Inc Stock (SLRX) Price Forecast for 2029
The 2029 price forecast for Salarius Pharmaceuticals Inc Stock (SLRX) is $107.74 on average, with a high prediction of $214.55 and a low estimate of $0.9331. This represents an +7,382% increase from the previous price of $1.44.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $40.41 | $40.44 | $43.24 | +2,706% |
| February, 2029 | $36.96 | $37.03 | $39.47 | +2,466% |
| March, 2029 | $33.53 | $33.64 | $36.07 | +2,228% |
| April, 2029 | $30.22 | $30.28 | $32.66 | +1,999% |
| May, 2029 | $25.80 | $25.88 | $29.23 | +1,692% |
| June, 2029 | $22.41 | $22.43 | $24.92 | +1,456% |
| July, 2029 | $18.98 | $19.10 | $21.53 | +1,218% |
| August, 2029 | $14.74 | $14.79 | $18.06 | +923.71% |
| September, 2029 | $11.24 | $11.31 | $13.84 | +680.67% |
| October, 2029 | $6.8588 | $6.8989 | $10.28 | +376.31% |
| November, 2029 | $3.5138 | $3.539 | $5.8629 | +144.02% |
| December, 2029 | $255.18 | $0.9331 | $214.55 | +17,621% |
Salarius Pharmaceuticals Inc Stock (SLRX) Price Forecast for 2030
Salarius Pharmaceuticals Inc Stock (SLRX) is expected to reach an average price of $281.31 in 2030, with a high forecast of $412.30 and a low forecast of $150.32. This signifies an +19,435% surge from the last price of $1.44.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $102.12 | $187.12 | $237.96 | +6,992% |
| February, 2030 | $10.45 | $162.68 | $163.51 | +625.40% |
| March, 2030 | $352.61 | $150.32 | $313.86 | +24,387% |
| April, 2030 | $273.78 | $292.65 | $323.64 | +18,913% |
| May, 2030 | $337.99 | $286.93 | $332.24 | +23,371% |
| June, 2030 | $343.04 | $342.50 | $328.73 | +23,722% |
| July, 2030 | $367.86 | $346.82 | $361.77 | +25,446% |
| August, 2030 | $355.39 | $356.17 | $350.38 | +24,580% |
| September, 2030 | $351.48 | $352.20 | $346.73 | +24,308% |
| October, 2030 | $413.04 | $371.74 | $412.30 | +28,584% |
| November, 2030 | $408.49 | $407.84 | $407.59 | +28,268% |
| December, 2030 | $404.91 | $405.91 | $407.18 | +28,019% |
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):